Charles River Laboratories
CRL
CRL
622 hedge funds and large institutions have $10.3B invested in Charles River Laboratories in 2024 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 203 increasing their positions, 271 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 271
33% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 97
38% less call options, than puts
Call options by funds: $59M | Put options by funds: $94.8M
Holders
622
Holding in Top 10
6
Calls
$59M
Puts
$94.8M
Top Buyers
| 1 | +$736M | |
| 2 | +$198M | |
| 3 | +$100M | |
| 4 |
IC
Impactive Capital
New York City,
New York
|
+$74.1M |
| 5 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$59.2M |
Top Sellers
| 1 | -$167M | |
| 2 | -$102M | |
| 3 | -$94.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$92.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$63.7M |